Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

Science
Brett E JohnsonJoseph F Costello

Abstract

Tumor recurrence is a leading cause of cancer mortality. Therapies for recurrent disease may fail, at least in part, because the genomic alterations driving the growth of recurrences are distinct from those in the initial tumor. To explore this hypothesis, we sequenced the exomes of 23 initial low-grade gliomas and recurrent tumors resected from the same patients. In 43% of cases, at least half of the mutations in the initial tumor were undetected at recurrence, including driver mutations in TP53, ATRX, SMARCA4, and BRAF; this suggests that recurrent tumors are often seeded by cells derived from the initial tumor at a very early stage of their evolution. Notably, tumors from 6 of 10 patients treated with the chemotherapeutic drug temozolomide (TMZ) followed an alternative evolutionary path to high-grade glioma. At recurrence, these tumors were hypermutated and harbored driver mutations in the RB (retinoblastoma) and Akt-mTOR (mammalian target of rapamycin) pathways that bore the signature of TMZ-induced mutagenesis.

References

Dec 18, 1998·The Journal of Investigative Dermatology·M C FargnoliK Peris
Nov 5, 1999·Methods in Molecular Biology·S Rozen, H Skaletsky
Jan 15, 2004·Human Mutation·C HoudayerD Stoppa-Lyonnet
Feb 11, 2004·Archives of Ophthalmology·Tony TsaiJoan M O'Brien
Jun 9, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Huamin WangGregory N Fuller
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sohye KangPeter K Vogt
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Nov 17, 2006·Nature Reviews. Cancer·Lauren M F MerloCarlo C Maley
Jan 20, 2007·Bioinformatics·E S Venkatraman, Adam B Olshen
Mar 9, 2007·Nature·Christopher GreenmanMichael R Stratton
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel P CahillDavid N Louis
Nov 28, 2007·Annual Review of Pathology·David N Louis
Apr 5, 2008·Human Mutation·Pedro P MedinaMontse Sanchez-Cespedes
Apr 23, 2008·Current Protocols in Human Genetics·S A ForbesM R Stratton
May 17, 2008·Cancer Research·Selina GlarosDavid Reisman
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Peter J CampbellMichael R Stratton
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Sep 12, 2008·PloS One·Barry S TaylorChris Sander
Feb 28, 2009·The American Journal of Pathology·Takuya WatanabeHiroko Ohgaki
Mar 18, 2009·Bioinformatics·Cole TrapnellSteven L Salzberg
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jul 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen YipDavid N Louis
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Jul 9, 2010·Nature·Alika K MaunakeaJoseph F Costello
Sep 14, 2010·Nature Methods·Malachi GriffithMarco A Marra
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Peter Van LooVessela N Kristensen
Oct 15, 2010·The New England Journal of Medicine·Kimberly C WiegandDavid G Huntsman
Oct 29, 2010·Nature·Gonçalo R AbecasisGil A McVean
Oct 29, 2010·Nature·Shinichi YachidaChristine A Iacobuzio-Donahue
Dec 18, 2010·Journal of the National Cancer Institute·Brock C ChristensenJohn K Wiencke
Feb 11, 2011·Nature·Michael F BergerLevi A Garraway
Mar 25, 2011·Nature·Michael A ChapmanTodd R Golub
Aug 4, 2011·Nature Reviews. Neuroscience·Manfred Westphal, Katrin Lamszus
Nov 3, 2011·Journal of Neurosurgery·Nader SanaiMitchel S Berger
Jan 20, 2012·Nature·Mel Greaves, Carlo C Maley
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Nicholas J SzerlipCameron W Brennan
Feb 22, 2012·Nature·Xiaochong WuMichael D Taylor
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
May 23, 2012·Cell·Serena Nik-ZainalUNKNOWN Breast Cancer Working Group of the International Cancer Genome Consortium

❮ Previous
Next ❯

Citations

Jun 24, 2014·Biochemistry. Biokhimii︠a︡·A V Lichtenstein
Mar 13, 2014·Acta neurochirurgica·Juha E Jääskeläinen, Emília Gaál-Paavola
Jul 6, 2014·Journal of Neuro-oncology·Manmeet S Ahluwalia, Susan M Chang
Jul 20, 2014·Current Neurology and Neuroscience Reports·Marlo R Firme, Marco A Marra
Jul 2, 2014·Cellular Oncology (Dordrecht)·Ad Geurts van Kessel
Oct 26, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F AndreC Swanton
Aug 1, 2014·Acta Neuropathologica·Adam M FontebassoNada Jabado
Oct 8, 2014·Annual Review of Cell and Developmental Biology·Dan FilipescuGeneviève Almouzni
Dec 2, 2014·Neurosurgical Focus·Diane J AumAlbert H Kim
Dec 2, 2014·Neurosurgical Focus·Sameer AgnihotriGelareh Zadeh
Oct 9, 2014·Annual Review of Genetics·Marco GerlingerCharles Swanton
Oct 10, 2014·Nature Protocols·Scott R KennedyLawrence A Loeb
Dec 24, 2014·Stem Cell Reports·Sara G M PiccirilloMel Greaves
Sep 24, 2015·Critical Reviews in Clinical Laboratory Sciences·Anthony J Apostoli, Laurie Ailles
Jul 12, 2014·Pharmaceuticals·Catherine L Moody, Richard T Wheelhouse
May 20, 2015·Expert Review of Anticancer Therapy·Tareq A JuratliIan E McCutcheon
Sep 24, 2015·Expert Review of Molecular Diagnostics·Mehdi TouatAhmed Idbaih
Jan 9, 2015·International Journal of Molecular Sciences·Ting ZhouVivienne I Rebel
Nov 6, 2015·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Francesco Gatto, Jens Nielsen
Jan 7, 2015·Proceedings of the National Academy of Sciences of the United States of America·Mona MeyerPeter B Dirks
Mar 5, 2016·Mutation Research·Mark A MilesChristine J Hawkins
Dec 19, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Shuai Ye, T S Karin Eisinger-Mathason
Dec 23, 2015·Trends in Genetics : TIG·Xueda Hu, Zemin Zhang
Jan 24, 2015·Current Opinion in Genetics & Development·Joanna Wang, Chetan Bettegowda
Jan 14, 2016·Nature·A Sorana MorrissyMichael D Taylor
May 29, 2015·Annals of Neurology·Vincent GleizeMarc Sanson
Sep 29, 2015·The American Journal of Surgical Pathology·Seiji YamadaAditya Raghunathan
Dec 1, 2015·The Journal of Clinical Investigation·Matthew L HedbergJennifer R Grandis
Mar 5, 2016·Journal of Hematology & Oncology·Francesco Gatto, Jens Nielsen
Nov 26, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·K M FieldA K Nowak
Dec 19, 2015·Cancer Cell·Kensuke TateishiDaniel P Cahill
Dec 10, 2015·BMC Medicine·Brett J Theeler, Mark R Gilbert
Mar 13, 2016·Biochimica Et Biophysica Acta·A K RoojJ Godlewski
Dec 4, 2015·Current Opinion in Oncology·James KohJulie A Sosa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Tae-Young JungIn-Ah Kim
Nederlands tijdschrift voor geneeskunde
W TaalM J van den Bent
© 2021 Meta ULC. All rights reserved